Oracle falls 8.9% after disclosing $20 billion stock and bond offering to finance AI build-out

What happened

Oracle (ORCL) fell 8.9% on November 2, 2026, after it disclosed and priced a concurrent offering to raise about $20 billion to fund its AI infrastructure build-out. The company said it would sell 86,206,897 shares of common stock at $116.00 per share. It also priced multiple senior notes, including $2,000,000,000 of 7.000% notes due 2029 and $1,750,000,000 of 7.450% notes due 2031, to finance the AI infrastructure build-out and for general corporate purposes, according to Reuters and CNBC. The stock opened 3.7% below the previous close and finished the session at $119.10.

How big was the move

The stock fell 8.9% on the day, a move that was 2.4 times a typical daily move for this stock and 7.4 percentage points worse than the technology sector median. Trading volume was 1.8 times its 20-day average, signaling heavier-than-normal activity. The S&P 500 fell 0.5% on the same day and the technology sector median fell 1.5%, so the stock moved far more than the market and its sector, suggesting the company news was the likely driver. Over the last five sessions the stock fell 5.5% while the S&P 500 over five sessions fell 1.8%.

The technical picture

The stock closed 10.8% below its 20-day moving average, 15.7% below its 50-day moving average and 24.0% below its 200-day moving average. The 50-day average was below the 200-day average, a sign of a weak longer-term trend. The stock was 55.2% below the 52-week high and its Relative Strength Index (14 days) was 38, a neutral reading between 30 and 70. Volatility was 59% annualized over 60 days, higher than 89% of its own readings over five years.

The stock had fallen 16.3% over one month, 18.3% over three months and 53.6% over one year, leaving it 64.2 percentage points behind the S&P 500 over the same period. In the past five years the stock had five sessions with a decline of at least 8.9%; twenty trading days later the median result was a gain of 2.9% and four of five were higher. Its beta of 1.84 shows the stock tends to move more than the market, and the outsized reaction on November 2 reinforced that pattern.

Fundamentals and valuation

For the four quarters through August 31, 2026, revenue was $71.78 billion, up 21.6% from a year earlier. Diluted earnings per share for that period were $6.38, a rise of 47.7% from a year earlier. Gross margin was 63.9% (a year earlier: 69.7%); operating margin was 32.4% (a year earlier: 30.4%); and the free-cash-flow margin was 40.0%.

Return on invested capital was 7.7% and the balance sheet showed net debt of 3.2 times EBITDA. Share count over one year increased by 3.1%.

The stock trades at 18.7 times trailing earnings, the lowest reading of the past five years (five-year median: 32.6 times earnings). Price to forward earnings was 14.6 times expected earnings and the free-cash-flow yield was 7.3%. Those valuation metrics show investors are assigning a much lower multiple than in prior years even as revenue and earnings growth accelerated.

PromtFinance scores highlight the contrast between strong growth and weak price momentum. The company scored 84 for Growth (Strong) and 79 for Revisions (Positive). It scored 67 for Value (Positive) and 74 for Quality (Positive). Momentum was 8 (Very weak) and Stability was 26 (Very weak).

Earnings and analyst expectations

The company last reported on September 10, 2026, with earnings per share of $1.92 against $1.74 expected, 10.3% above estimates. That marked four consecutive quarters beating estimates, with an average surprise over the last four reports of 15.3% above estimates. Typical two-day reactions after recent reports showed the stock fell 1.6%. Oracle was scheduled to report next on December 9, 2026.

Analysts covering the stock numbered 87, with 67% rating the stock Buy or Strong Buy and a consensus rating of Buy. The consensus price target was $230.88, which was 93.9% above the closing price.

What to watch

• December 9, 2026: Oracle next scheduled earnings report.
• The final terms and settlement details of the concurrent offering consisting of 86,206,897 shares at $116.00 per share and the issued senior notes, including the $2,000,000,000 of 7.000% notes due 2029 and $1,750,000,000 of 7.450% notes due 2031.
• Any company commentary on the use of proceeds for the AI infrastructure build-out and general corporate purposes.
• Trading volume relative to its 20-day average in the days following the offering announcement.
• Changes in analyst estimates or consensus rating among the 87 analysts covering the stock.